Retrospective Cohort Study
Copyright ©The Author(s) 2019.
World J Diabetes. Mar 15, 2019; 10(3): 189-199
Published online Mar 15, 2019. doi: 10.4239/wjd.v10.i3.189
Table 1 Demographic data: Participants with type 1 diabetes and their first-degree relatives n (%)
DemographicsT1D only (n = 280)T1D + CD (n = 22)FDR only (n = 689)FDR +CDA (n = 36)
White249 (88.9)22 (100)629 (91.3)35 (97.2)
Not hispanic188 (67.1)15 (68.2)451 (65.5)27 (75.0)
Female178 (63.6)17 (77.3)409 (59.4)26 (72.2)
Age at screening (yr), median (range)19 (2-72)14.5 (7-43)40 (1-74)39.5 (3-55)
Age at diagnosis of T1D (yr), median (range)10 (0.1-64)6.5 (1-21)
Presence of gastrointestinal symptoms (GI sx)113 (40.5)6 (27.3)216 (31.4)13 (36.1)
Presence of extraintestinal symptoms (Ex sx)78 (27.9)3 (13.6)176 (25.5)7 (19.4)
Both GI and Ex symptoms56 (20)3 (13.6)98 (14.2)4 (11.1)
Asymptomatic144 (51.6)16 (72.7)394 (57.3)20 (55.6)
Human leukocyte antigen (HLA) genotype
DR3-DQ249 (18)2 (9.1)148 (21.8)10 (28.6)
DR3-DQ2 homozygote18 (6.6)3 (13.6)25 (3.7)3 (8.6)
DR7-DQ212 (4.4)1 (4.6)41 (6.1)2 (5.7)
DR7-DQ2 homozygote2 (0.7)0 (0)13 (1.9)0 (0)
DR3/DR7-DQ2 homozygote1 (0.37)0 (0)20 3.0)3 (8.6)
DR4-DQ883 (30.5)5 (22.7)205 (30.2)10 (28.6)
DR3-DQ2/DR4-DQ870 (25.7)7 (31.8)50 (7.4)6 (17.1)
DR7-DQ2/DR4-DQ86 (2.2)4 (18.2)33 (4.9)0 (0)
DQ2/DQ8 negative31 (11.4)0 (0)142 (20.9)1 (2.9)
Haptoglobin genotype (HP) (Zonulin)
HP 1-146 (16.4)2 (9.1)120 (17.4)8 (22.2)
HP 2-1118 (42.1)10 (45.5)278 (40.4)21 (58.3)
HP 2-2116 (41.4)10 (45.5)290 (42.2)7 (19.4)
Any HP2234 (83.6)20 (90.9)568 (82.6)28 (77.7)
Table 2 Cohort prevalence of celiac disease and celiac disease autoimmunity
nCDCDACD at screeningCDA at screeningCDA prevalence estimation
Type 1 diabetes3028 (2.7)3 (1.0)8 (2.5)3 (0.7)22 (7.3)
First-degree relative7259 (1.2)4 (0.6)18 (2.7)5 (1.0)36 (5.0)
Table 3 Univariate and multiple regression models: Factors related to celiac disease autoimmunity in participants with type 1 diabetes
EstimateSeLower limitUpper limitZ statP-value
Univariate Model (exchangeable correlation)
Female0.65620.5151-0.35341.66591.270.2027
Age-0.03140.0152-0.0611-0.0017-2.070.0383A
Onset of T1D-0.06580.0342-0.13290.0013-1.920.0546
Gastrointestinal (GI) symptoms-0.58120.491-1.54350.3811-1.180.2365
Extraintestinal (EX) symptoms-0.92040.6391-2.17310.3323-1.440.1498
Both GI and EX symptoms-0.47240.6385-1.72390.7791-0.740.4594
No GI or EX symptoms0.90740.4931-0.0591.87371.840.0657
Human Leukocyte Antigen (HLA) DQ2-DR3 Heterozygous-0.74020.7571-2.22410.7437-0.980.3282
HLA DQ2-DR3 Homozygous0.78430.67-0.53322.10191.170.2433
HLA DQ2-DR7 Heterozygous0.0281.0649-2.05922.11520.030.979
HLA DQ8-0.39750.5234-1.42330.6283-0.760.4475
HLA DQ2-DR3/DQ80.27670.4814-0.66681.22030.570.5654
HLA DQ2-DR7/DQ82.48510.65071.20983.76043.820.0001B
HLA DQ2 Heterozygous-0.5750.6367-1.8230.6729-0.90.3665
HLA DQ2 Homozygous0.61920.666-0.68621.92460.930.3525
Haptoglobin genotype (HP) 1-1-0.69320.7671-2.19670.8104-0.90.3662
HP 2-10.15390.4414-0.71121.01910.350.7273
HP 2-20.15250.4422-0.71411.01920.340.7301
Any HP20.6930.767-0.812.1970.90.366
First degree relative (FDR) with celiac disease (CD)1.40910.61880.19622.6222.280.0228C
FDR with Type 1 diabetes (T1D)0.07240.557-1.01931.16410.130.8966
FDR with thyroid disease0.78390.4619-0.12151.68921.70.0897
FDR with other autoimmune disease1.16340.44320.29472.03212.620.0087D
CD in another relative0.41360.6598-0.87961.70680.630.5307
Multiple Regression Model (independence working correlation)
Intercept-3.32130.927-5.1383-1.5043-3.580.0003
Age-0.01210.019-0.04940.0252-0.640.5246
Onset of T1D-0.03960.0425-0.12290.0436-0.930.3509
DQ2-DR7/DQ82.41310.84010.76664.05962.870.0041E
No GI or EX symptoms1.19050.6566-0.09632.47741.810.0698
FDR with CD0.69271.3443-1.94213.32740.520.6064
FDR with thyroid disease-0.89761.6214-4.07562.2804-0.550.5799
FDR with other autoimmune disease1.97651.7861-1.52415.47711.110.2685
Table 4 Univariate and multiple regression models: Factors related to celiac disease autoimmunity in first degree relatives of participants with type 1 diabetes
EstimateSeLower limitUpper limitZ statP-value
Univariate model (exchangeable correlation)
White1.260.88-0.472.981.430.154
Female0.54330.3674-0.17681.26351.480.1392
Age-0.00460.0097-0.02360.0144-0.470.6355
Gastrointestinal (GI) symptoms0.25510.3395-0.41030.92060.750.4524
Extraintestinal (EX) symptoms-0.37480.4596-1.27560.526-0.820.4148
Both GI and EX symptoms-0.27150.5305-1.31130.7682-0.510.6087
No GI or EX symptoms-0.0850.3419-0.75510.5851-0.250.8036
Human Leukocyte Antigen (HLA) DQ2-DR3 Heterozygous0.42550.383-0.32511.17611.110.2666
HLA DQ2-DR3 Homozygous0.80420.7654-0.6962.3041.050.2934
HLA DQ2-DR7 Heterozygous-0.03760.6636-1.33821.263-0.060.9548
HLA DQ2-DR3/DR7 Homozygous1.020.715-0.3812.421.430.153
HLA DQ8-0.09810.4058-0.89340.6972-0.240.809
HLA DQ2-DR3/DQ80.92720.4720.00211.85231.960.0495A
HLA DQ2/DQ8 Negative-2.18361.0232-4.1891-0.1781-2.130.0328B
HLA DQ2 Heterozygous0.35610.388-0.40431.11660.920.3586
HLA DQ2 Homozygous0.68420.5435-0.38111.74951.260.2081
Haptoglobin genotype (HP) 1-10.29010.4341-0.56071.14090.670.5039
HP 2-10.68230.34290.01031.35441.990.0466C
HP 2-2-1.07630.4252-1.9096-0.2429-2.530.0114D
Any HP2-0.290.434-1.1410.561-0.670.503
First degree relative (FDR) with CDceliac disease (CD)1.67680.38090.93032.42334.4<.0001E
FDR with thyroid disease-0.5030.4849-1.45330.4473-1.040.2995
FDR with other autoimmune disease0.68170.3606-0.0251.38841.890.0587
CD in other relative0.52170.7115-0.87281.91610.730.4634
Multiple regression model (independence working correlation)
Intercept-2.88290.404-3.6746-2.0912-7.14< 0.0001
HLA DQ2-DR3/DQ80.94070.5381-0.11391.99531.750.0804
HLA DQ2/DQ8 Negative-1.93481.0275-3.94870.0791-1.880.0597
HP 2-10.08040.4492-0.80010.96090.180.858
HP 2-2-1.01490.563-2.11850.0886-1.80.0715
FDR with CD2.36350.75760.87873.84833.120.0018F
FDR with other autoimmune disease-0.82690.7245-2.24680.5932-1.140.2538